Tag: Rabies Monoclonal Antibody Market

Introduction: Rabies remains a deadly viral disease that poses a significant threat to public health globally. While preventive measures such as vaccination of animals and post-exposure prophylaxis (PEP) for humans have been effective in reducing rabies incidence, there is an ongoing need for innovative treatments to combat the disease. In recent years, monoclonal antibodies (mAbs)…
Read more